TRP beats Q1 earnings estimates, boosts dividend and posts strong segment growth, even as revenues miss expectations and outlook stays intact.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
TRP beats Q1 earnings estimates, boosts dividend and posts strong segment growth, even as revenues miss expectations and outlook stays intact.
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
CVX distributes $6 billion to its shareholders, including $2.5 billion in buybacks and $3.5 billion in dividends during the first quarter
NOV Q1 earnings miss estimates as Middle East disruptions hit operations, while revenues edge past expectations despite a year-over-year decline.
Core Laboratories (NYSE:CLB) executives said first-quarter 2026 results were significantly affected by geopolitical and weather-related disruptions, with the escalation of military conflict in the Middle East creating meaningful project delays, halting some hydrocarbon production, and disrupting mar